AHCC Soft Capsule Active Hexose Correlated Compound

The medical literature documents the use of AHCC (active hexose correlated compound) as an immunomodulatory agent, as well as efficacy as an adjuvant in cancer treatment and various infections. Clinical trials have also examined the use of AHCC in the treatment of inflammatory bowel disease (IBD) and as a hepatoprotective agent. However, clinical data are lacking to recommend AHCC for any of these indications.